Tumor necrosis factor-α and Fas activate complementary Fas-associated death domain-dependent pathways that enhance apoptosis induced by γ-irradiation

被引:45
作者
Kimura, K [1 ]
Gelmann, EP [1 ]
机构
[1] Georgetown Univ, Lombardi Canc Ctr, Dept Oncol, Washington, DC 20007 USA
关键词
D O I
10.1074/jbc.275.12.8610
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of either tumor necrosis factor receptor I or Fas induces a low level of programmed cell death in LNCaP human prostate cancer cells. We have shown that LNCaP cells are entirely resistant to gamma-radiation-induced apoptosis, but can be sensitized to irradiation by TNF-alpha. Fas activation also sensitized LNCaP cells to irradiation, causing nearly 40% cell death 72 h after irradiation. Caspase-8 was cleaved and activated after exposure to tumor necrosis factor (TNF)-alpha. However, after exposure to anti-Fas antibody caspase-8 cleavage occurred only between the 26-kDa N-terminal prodomain and the 28-kDa C-terminal region that contains the protease components. Although anti-Fas antibody plus irradiation induced apoptosis that could be blocked by the pancaspase inhibitor zVAD, there was no measurable caspase-8 activity after exposure to anti-Fas antibody. The effector caspases-6 and -7, and to a lesser extent caspase-3, were activated by TNF-alpha, but not by anti-Fas antibody. Anti-Fas antibody, like TNF-or also activated serine proteases that contributed to cell death. Exposure of LNCaP cells simultaneously to TNF-alpha and anti-Fas antibody CH-11 resulted in marked enhancement of apoptosis that occurred very rapidly and was still further augmented by irradiation. Rapid apoptosis that ensued from combined treatment with TNF-alpha, anti-Fas antibody, and irradiation was completely blocked either by zVAD or expression of dominant negative Fas-associated death domain. Our data shows that there are qualitative differences in caspase activation resulting from either TNF receptor 1 or Fas, Simultaneous activation of these receptors was synergistic and caused rapid epithelial cell apoptosis mediated by the caspase cascade.
引用
收藏
页码:8610 / 8617
页数:8
相关论文
共 55 条
[31]   DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis [J].
Liu, XS ;
Zou, H ;
Slaughter, C ;
Wang, XD .
CELL, 1997, 89 (02) :175-184
[32]   REQUIREMENT OF AN ICE/CED-3 PROTEASE FOR FAS/APO-1-MEDIATED APOPTOSIS [J].
LOS, M ;
VANDECRAEN, M ;
PENNING, LC ;
SCHENK, H ;
WESTENDORP, M ;
BAEUERLE, PA ;
DROGE, W ;
KRAMMER, PH ;
FIERS, W ;
SCHULZEOSTHOFF, K .
NATURE, 1995, 375 (6526) :81-83
[33]   Ceramide induces apoptosis via CPP32 activation [J].
Mizushima, N ;
Koike, R ;
Kohsaka, H ;
Kushi, Y ;
Handa, S ;
Yagita, H ;
Miyasaka, N .
FEBS LETTERS, 1996, 395 (2-3) :267-271
[34]   HORMONAL-REGULATION OF PROSTATE-SPECIFIC ANTIGEN (PSA) GLYCOPROTEIN IN THE HUMAN PROSTATIC ADENOCARCINOMA CELL-LINE, LNCAP [J].
MONTGOMERY, BT ;
YOUNG, CYF ;
BILHARTZ, DL ;
ANDREWS, PE ;
PRESCOTT, JL ;
THOMPSON, NF ;
TINDALL, DJ .
PROSTATE, 1992, 21 (01) :63-73
[35]   FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex [J].
Muzio, M ;
Chinnaiyan, AM ;
Kischkel, FC ;
ORourke, K ;
Shevchenko, A ;
Ni, J ;
Scaffidi, C ;
Bretz, JD ;
Zhang, M ;
Gentz, R ;
Mann, M ;
Krammer, PH ;
Peter, ME ;
Dixit, VM .
CELL, 1996, 85 (06) :817-827
[36]   A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes [J].
Newton, K ;
Harris, AW ;
Bath, ML ;
Smith, KGC ;
Strasser, A .
EMBO JOURNAL, 1998, 17 (03) :706-718
[37]   The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A [J].
Orth, K ;
Chinnaiyan, AM ;
Garg, M ;
Froelich, CJ ;
Dixit, VM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16443-16446
[38]  
Pflug BR, 1999, PROSTATE, V40, P269, DOI 10.1002/(SICI)1097-0045(19990901)40:4<269::AID-PROS9>3.0.CO
[39]  
2-6
[40]   Potentiation of Fas-mediated apoptosis of murine granulosa cells by interferon-γ, tumor necrosis factor-α, and cycloheximide [J].
Quirk, SM ;
Porter, DA ;
Huber, SC ;
Cowan, RG .
ENDOCRINOLOGY, 1998, 139 (12) :4860-4869